Pharmacological evaluation of novel 5-HT 3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery

• Những tác giả chính: Deepali Gupta (Tác giả), Mahesh Radhakrishnan (Tác giả), Devadoss Thangaraj (Tác giả), Yeshwant Kurhe (Tác giả)
• Định dạng: Sách
• Được phát hành: Wolters Kluwer Medknow Publications, 2015-01-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

Objective: In the last few decades, serotonin type-3 (5-HT 3 ) receptor antagonists have been identified as potential targets for anxiety disorders. In preclinical studies, 5-HT 3 antagonists have shown promising antianxiety effects. In this study, a novel 5-HT 3 receptor antagonist, QCM-13(N-cycloh...